$0.0911
At close: Mar 15, 9:25 AM EDT
$0.0330
-0.06-63.78%
After Hours: Mar 15, 9:25 AM EDT
Comments
Loading...
Statera BioPharma (OTC:STAB) Stock, Earnings Estimates, EPS, And Revenue
Statera BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.070
Quarterly Revenue
$670.47K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Statera BioPharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Statera BioPharma (STAB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Statera BioPharma (STAB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Statera BioPharma (OTCEM:STAB) reporting earnings?
Statera BioPharma (STAB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2022 for Q3.
What were the latest earnings per share (EPS) for Statera BioPharma (OTCEM:STAB)?
Statera BioPharma (STAB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2022 for Q3 and the Actual EPS was $-0.07, which missed the estimate of $0.00.
What were Statera BioPharma’s (OTCEM:STAB) revenues?
Statera BioPharma (STAB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2022 for Q3 and the Actual Revenue was $670.5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.